Aberdeen Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.75M Sell
11,249
-123
-1% -$28.6K 1.25% 16
2025
Q4
$2.35M Sell
11,372
-156
-1% -$30.8K 1.09% 18
2025
Q3
$2.14M Buy
11,528
+4
+0% +$685 1.34% 19
2025
Q2
$1.76M Sell
11,524
-257
-2% -$39.5K 1.17% 22
2025
Q1
$1.95M Sell
11,781
-169
-1% -$26.4K 1.35% 18
2024
Q4
$1.73M Sell
11,950
-401
-3% -$62.1K 1.18% 19
2024
Q3
$2M Sell
12,351
-1,733
-12% -$276K 1.32% 18
2024
Q2
$2.06M Sell
14,084
-517
-4% -$76.9K 1.39% 16
2024
Q1
$2.31M Buy
14,601
+1,660
+13% +$264K 1.34% 15
2023
Q4
$2.03M Sell
12,941
-1,761
-12% -$270K 1.47% 14
2023
Q3
$2.29M Sell
14,702
-1,410
-9% -$233K 1.73% 10
2023
Q2
$2.67M Sell
16,112
-242
-1% -$39.1K 1.93% 9
2023
Q1
$2.53M Buy
16,354
+7
+0% +$1.13K 1.89% 9
2022
Q4
$2.89M Sell
16,347
-93
-0.6% -$16.1K 2.18% 8
2022
Q3
$2.69M Buy
16,440
+7
+0% +$1.19K 2.37% 6
2022
Q2
$2.92M Sell
16,433
-43
-0.3% -$7.66K 2.32% 6
2022
Q1
$2.92M Buy
16,476
+6
+0% +$1.02K 1.99% 8
2021
Q4
$2.82M Sell
16,470
-8
-0% -$1.31K 1.84% 8
2021
Q3
$2.66M Sell
16,478
-442
-3% -$75.4K 2.58% 5
2021
Q2
$2.79M Buy
16,920
+7
+0% +$1.16K 2.57% 5
2021
Q1
$2.78M Sell
16,913
-316
-2% -$51.1K 2.21% 6
2020
Q4
$2.71M Buy
17,229
+329
+2% +$48.5K 2.05% 7
2020
Q3
$2.52M Sell
16,900
-1,820
-10% -$269K 2.4% 6
2020
Q2
$2.63M Buy
18,720
+1,558
+9% +$227K 2.82% 4
2020
Q1
$2.25M Buy
17,162
+7
+0% +$993 2.74% 5
2019
Q4
$2.5M Buy
+17,155
New +$2.33M 1.86% 7

Other funds holding JNJ

Aberdeen Wealth Management's JNJ Position: Q1 2026 in Review

Aberdeen Wealth Management reduced its Johnson & Johnson (JNJ) stake by 1.1% in Q1 2026, selling an estimated $28.6K and leaving 11,249 shares worth $2.75M. The position accounts for 1.25% of the portfolio, ranked #16.

Aberdeen Wealth Management first reported a position in JNJ in Q4 2019 and has held it in 26 quarters since. The position peaked at $2.92M in Q1 2022. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Aberdeen Wealth Management held 11,249 shares of Johnson & Johnson worth $2.75M as of Q1 2026.
  • Aberdeen Wealth Management sold 123 Johnson & Johnson shares in Q1 2026, an estimated $28.6K.
  • Johnson & Johnson made up 1.25% of Aberdeen Wealth Management's portfolio in Q1 2026, its #16 holding.
  • Aberdeen Wealth Management first reported a position in Johnson & Johnson in Q4 2019 and has held it in 26 quarters since.
  • Aberdeen Wealth Management's Johnson & Johnson position peaked at $2.92M in Q1 2022.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Aberdeen Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.